Detalles de la búsqueda
1.
Targeting Calcium Release-activated Calcium Channel Is Not Sufficient to Prevent Rejection in Nonhuman Primate Kidney Transplantation.
Transplantation
; 104(5): 970-980, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32317615
2.
Determination of the mechanism of action of anti-FasL antibody by epitope mapping and homology modeling.
Biochemistry
; 48(30): 7251-60, 2009 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-19588926
3.
Evaluation of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy After Single and Multiple Dosings of LY3016859 in Healthy Subjects and Patients With Diabetic Nephropathy.
Clin Pharmacol Drug Dev
; 7(7): 759-772, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29385323
4.
LY3045697: Results from two randomized clinical trials of a novel inhibitor of aldosterone synthase.
J Renin Angiotensin Aldosterone Syst
; 18(3): 1470320317717883, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28814143
5.
Population pharmacokinetic modeling of LY2189102 after multiple intravenous and subcutaneous administrations.
AAPS J
; 16(5): 1009-17, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24912797
6.
Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1ß antibody, in patients with type 2 diabetes.
Diabetes Care
; 36(8): 2239-46, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23514733
Resultados
1 -
6
de 6
1
Próxima >
>>